Web Exclusives

4-drug combination regimen effective for TB

Compared to separate drug administration, a 4-drug combination regimen had comparable effectiveness in patients with tuberculosis according to a study in JAMA. Read more…

FDA approves new treatment for metastatic melanoma

The U.S. Food and Drug Administration has approved Yervoy (ipilimumab) for the treatment of patients with metastatic melanoma. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm.

Davol XenMatrix Surgical Graft recall

The U.S. Food and Drug Administration notified healthcare professionals that several lots of XenMatrix Surgical Graft have been recalled because of elevated endotoxin levels.…

Negative effects of ARDS linger

Five years after having acute respiratory distress syndrome (ARDS), survivors still had not recovered to normal physical function, and many other physical and psychological…

NEJM: Perspective on foodborne diseases

The Feb. 23 issue of The New England Journal of Medicine (NEJM) includes a perspective on foodborne disease. Read it at http://www.nejm.org/doi/full/10.1056/NEJMp1010907.

FDA approves new treatment for metastatic melanoma

The U.S. Food and Drug Administration has approved Yervoy (ipilimumab) for the treatment of patients with metastatic melanoma. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm.

Davol XenMatrix Surgical Graft recall

The U.S. Food and Drug Administration notified healthcare professionals that several lots of XenMatrix Surgical Graft have been recalled because of elevated…

Negative effects of ARDS linger

Five years after having acute respiratory distress syndrome (ARDS), survivors still had not recovered to normal physical function, and many other physical…

NEJM: Perspective on foodborne diseases

The Feb. 23 issue of The New England Journal of Medicine (NEJM) includes a perspective on foodborne disease. Read it at http://www.nejm.org/doi/full/10.1056/NEJMp1010907.

Test Your Knowledge

Cannabis TYK

Which of the following best explains why clinicians face challenges in discussing medicinal marijuana with their patients?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.